Cancer News and Research

Latest Cancer News and Research

Chemotherapy and supportive care are a winning combination

Gastrointestinal cancer, including colorectal, is one of the most common groups of cancers to claim Western lives.

21 Jul 2004

Chemotherapy aimed at both cancer cells and their genetically normal cellular 'microenvironment' might improve the success of breast cancer treatment

In the first comprehensive survey of gene activity in each cell type composing normal and malignant breast tissue, scientists at Dana-Farber Cancer Institute have identified genes in non-cancerous supporting cells that can spur the growth of breast cancer cells.

20 Jul 2004

Discovery challenges current thinking about how a cancer develops and spreads

When a physician discovers cancer in a patient, the first thing the doctor wants to know is whether that cancer has spread, or "metastasized."

20 Jul 2004

Recently amended draft Human Tissue Bill remains confused and will endanger the continuation of vital medical research

The Royal Society today warned the UK Government that the recently amended draft Human Tissue Bill remains confused and will endanger the continuation of vital medical research.

19 Jul 2004

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

CancerVax Corporation has announced that its wholly owned subsidiaries, Tarcanta, Inc., and Tarcanta, Ltd. (Ireland), have obtained the exclusive rights to complete the clinical development of three specific active immunotherapeutic (SAI) product candidates that target the epidermal growth factor receptor (EGFR) signaling pathway for the treatment of cancer.

19 Jul 2004

Cincinnati should go smoke-free

Cincinnati has just begun to consider strengthening its smoking restrictions. Anything short of protecting all workers' health would be just blowing smoke.

19 Jul 2004

First international server to analyze genetic diversity on a large scale

Researchers from the Universitat Autònoma de Barcelona have developed the first international server that allows the user to analyze genetic diversity on a large scale.

19 Jul 2004

Safer and improved technologies for detecting and treating scoliosis

Calgary researchers, healthcare providers and local patients are working together to develop a high-tech imaging system for detecting and treating of scoliosis – a mysterious spinal condition that affects about one out of every 200 people, especially children.

17 Jul 2004

New compound that is designed to overcome Gleevec resistance

One of the truly spectacular success stories in modern oncology is the development and implementation of Gleevec, a drug that virtually halts the progress of chronic myeloid leukemia. Yet for some patients who harbor particularly stubborn genetic mutations, Gleevec fails miserably.

17 Jul 2004

The cervical screening programme has saved Britain from an epidemic of cervical cancer

Cancer Research UK scientists estimate in a report published today that systematic cervical screening, introduced in 1988, is preventing up to 5,000 deaths a year from the disease in Britain.

16 Jul 2004

3M granted FDA approval for cream to treat superficial basal cell carcinoma

3M announced today that the U.S. Food and Drug Administration (FDA) has approved the first prescription therapy in nearly a decade for the treatment of superficial basal cell carcinoma (sBCC), a type of nonmelanoma skin cancer.

16 Jul 2004

Online database of AIDS-related protein structures

Researchers who are either developing drug treatments for AIDS or studying the virus that causes the disease have a new resource - an online database of AIDS-related protein structures just unveiled for public use by the National Institute of Standards and Technology.

16 Jul 2004

Success of the UK’s national screening programme for cervical cancer

An epidemiological study in this week’s issue of THE LANCET highlights the success of the UK’s national screening programme for cervical cancer introduced in 1988.

15 Jul 2004

The cancer risk from plutonium exposure

Plutonium may be many times more dangerous than previously thought. The cancer risk from exposure inside the body could be 10 times higher than is allowed for in calculating international safety limits.

15 Jul 2004

8.5 million Euros to address a fundamental question on mitosis: How is cell division regulated?

Scientists at the European Molecular Biology Laboratory (EMBL) join forces with top scientists from eleven research institutes in Austria, Germany, Italy, France and the United Kingdom for “MitoCheck” – the largest integrated research project on cell cycle control within the European Commission’s 6th Framework Programme (FP6).

15 Jul 2004

Effective treatment for soft tissue sarcoma (rhabdomyosarcoma)

Rhabdomyosarcoma is a highly malignant aggressive form of soft tissue cancer in children, the causes of which are currently unknown. Although the fibrous growths can be found all over the body they commonly develop around the head, neck, bladder and testes in young boys.

15 Jul 2004

Two out of three survivors of childhood cancer have at least one chronic or late-occurring health problem following their cancer therapy

A review in the July/August issue of “CA: A Cancer Journal for Clinicians” reports that two out of three survivors of childhood cancer have at least one chronic or late-occurring health problem following their cancer therapy, with about one in three having serious or life-threatening complications. These effects are often seen decades after therapy.

15 Jul 2004

Targeted therapeutics capable of preventing or limiting the metastasis of skin cancer

An international team of scientists has identified an important molecular link involved in the spread – or metastasis – of melanoma to other organs such as the lungs.

15 Jul 2004

A drug derived from an ocean-growing sponge helps prevent the growth of cancer cells

A drug derived from an ocean-growing sponge teams up to enhance the performance of the yew tree derivative Taxol® (paclitaxel) in preventing the growth of cancer cells, according to research published in the July 15 issue of the journal Cancer Research.

15 Jul 2004

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Researchers seeking to direct cancer-killing immune cells against the deadliest brain tumors have three new targets that show promise in laboratory studies and in a Phase I patient trial, according to two articles in the July 15 issue of the journal Cancer Research.

15 Jul 2004

Cancer News and Research

Latest Cancer News and Research

Chemotherapy and supportive care are a winning combination

Chemotherapy aimed at both cancer cells and their genetically normal cellular 'microenvironment' might improve the success of breast cancer treatment

Discovery challenges current thinking about how a cancer develops and spreads

Recently amended draft Human Tissue Bill remains confused and will endanger the continuation of vital medical research

CancerVax may increase the survival of patients with advanced stage non-small-cell lung cancer

Cincinnati should go smoke-free

First international server to analyze genetic diversity on a large scale

Safer and improved technologies for detecting and treating scoliosis

New compound that is designed to overcome Gleevec resistance

The cervical screening programme has saved Britain from an epidemic of cervical cancer

3M granted FDA approval for cream to treat superficial basal cell carcinoma

Online database of AIDS-related protein structures

Success of the UK’s national screening programme for cervical cancer

The cancer risk from plutonium exposure

8.5 million Euros to address a fundamental question on mitosis: How is cell division regulated?

Effective treatment for soft tissue sarcoma (rhabdomyosarcoma)

Two out of three survivors of childhood cancer have at least one chronic or late-occurring health problem following their cancer therapy

Targeted therapeutics capable of preventing or limiting the metastasis of skin cancer

A drug derived from an ocean-growing sponge helps prevent the growth of cancer cells

Research that directs cancer-killing immune cells against the deadliest brain tumors shows promise

Cancer Research - Second Edition eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in